contains the active ingredient ganciclovir
Consumer Medicine Information
What is in this leaflet
This leaflet answers some common questions about CYMEVENE.
It does not contain all the available information.
It does not take the place of talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you being given CYMEVENE injection against the
benefits they expect it will have for you.
If you have any concerns about being given this medicine, ask your doctor or pharmacist.
Keep this leaflet.
You may need to read it again.
What CYMEVENE is used for
CYMEVENE contains the active ingredient ganciclovir.
CYMEVENE belongs to a class of medicines used to treat viral infections. It works by stopping certain viruses from growing
in the body.
CYMEVENE acts against a certain type of herpes virus called cytomegalovirus or CMV. CMV causes infections mainly in people
with poor immunity. Poor immunity can be caused by HIV/AIDS or some transplant medications.
CYMEVENE helps control CMV eye infections in AIDS patients and in other patients who have poor immunity, which if left untreated
can cause blindness. CYMEVENE it is not a cure for CMV eye infections and is not effective against any underlying HIV- infection.
CYMEVENE may also be used to treat CMV lung infections in bone marrow transplant patients.
CYMEVENE may also be used to prevent CMV infection and disease in patients following bone marrow or solid organ transplantation.
Ask your doctor if you have any questions about why CYMEVENE has been prescribed for you.
Your doctor, however, may have prescribed CYMEVENE for another purpose.
CYMEVENE is not addictive.
This medicine is available only with a doctor's prescription.
Before you are given CYMEVENE
Animal and other laboratory studies have shown CYMEVENE has caused infertility, birth defects and cancer. It is possible
that these effects may also occur in humans.
When you must not be given it
Do not use CYMEVENE if
1.you have had an allergic reaction to CYMEVENE or Vitrasert® implant, or other drugs from the same family: valganciclovir (Valcyte®); aciclovir (e.g. Zovirax®, Acyclo-V®, Acihexal®, Lovir® or Zyclir®); valaciclovir (e.g. Valtrex®, Zelitrex®, Xerebid®, Valnir®)
Some of the symptoms of an allergic reaction may include:
shortness of breath
wheezing or difficulty breathing
swelling of the face, lips, tongue or other parts of the body
rash, itching or hives on the skin.
2.you have very low blood counts for platelets (which help clotting) or neutrophils (a type of white blood cell which defends
against infection) or haemoglobin (a substance that carries oxygen in the blood)
your baby may absorb this medicine in the womb and therefore there is a high likelihood of harm to the baby
4.you are breast-feeding or intend to breast-feed
CYMEVENE may pass into breast milk and therefore there is a possibility that the breast-fed baby may be affected
5.the package is torn or shows signs of tampering
6.the expiry date (EXP) printed on the pack has passed.
If you take this medicine after the expiry date has passed, it may not work as well.
If you are not sure if you should be receiving CYMEVENE, talk to your doctor.
Use in Children
There is very little information available on the use of CYMEVENE in children less than 12 years and safety and effectiveness
in children has not been proven. Children that take CYMEVENE, when grown-up, have an increased risk of cancer and, also, adverse
effects when trying to have children of their own. Therefore CYMEVENE should only be used if these risks are outweighed by
the benefits of treatment.
Before you are given it
Tell your doctor if
1.you are allergic to any other medicines, foods, dyes or preservatives.
Especially any medicine which you have taken previously to treat your current condition (e.g. valganciclovir, valaciclovir)
2.you have any other health problems, especially the following:
you have a history of low blood counts for platelets (thrombocytopenia), neutrophils (neutropenia) or red blood cells/haemoglobin
you have or previously have had poor kidney function
3.you are pregnant or plan to become pregnant
4.you are breast feeding or plan to breast feed
5.you are a woman who could become pregnant and you are not using contraception
you must use a reliable form of contraception during CYMEVENE therapy, and for at least 30 days after stopping CYMEVNE, unless
you are not sexually active.
6.you are a sexually active man
you should use condoms during and for at least 90 days following treatment with CYMEVNE unless it is certain that your female
partner is not at risk of pregnancy.
If you have not told your doctor about any of the above, tell them before you start taking CYMEVENE.
Taking other medicines
Tell your doctor if you are taking any other medicines, including any that you have bought from a pharmacy, supermarket or
health food shop.
Some medicines may interfere with CYMEVENE. These medicines include:
probenecid (e.g. Benemid®)
zidovudine (AZT, Retrovir®, Combivir®)
didanosine (ddI or Videx®)
medicines for the treatment of cancer
other medicines for the treatment of HIV or HIV-related infections
mycophenolate mofetil (CellCept®), a medicine used to prevent rejection of transplanted organs
other medicines used to prevent rejection of transplated organs
These medicines may be affected by CYMEVENE, or may affect how well it works. You may need to receive different amounts of
your medicine, or you may need to receive different medicines. Your doctor will advise you.
Your doctor or pharmacist has more information on medicines to be careful with or avoid while receiving CYMEVENE.
Ask your doctor or pharmacist if you are not sure about this list of medicines.
How CYMEVENE is given
CYMEVENE is added to an infusion bag and given as a 'drip' into a vein, usually over a period of one hour. CYMEVENE is usually
given once or twice a day.
Your doctor will decide what dose of CYMEVENE you will receive. This depends on how serious your infection is as well as
your kidney function.
While you are receiving CYMEVENE
Things you must do
Tell all doctors, dentists and pharmacists who are treating you that you are being given CYMEVENE.
See your doctor regularly so that your CMV disease, blood cell counts and any other potential side effects may be monitored
If blood cell counts are low then this may reduce your ability to fight infection, or for your blood to clot efficiently.
If left undetected these effects on blood cells may contribute to death or serious illness.
If you have a CMV eye infection, you must also see your doctor regularly to monitor the condition of your retina (part of
Tell your doctor if you become pregnant while receiving CYMEVENE.
If there is a possibility of your partner becoming pregnant, a barrier contraceptive should be used while receiving CYMEVENE
and for 90 days after stopping.
Things you must not do
Do not take any other medicines whether they require a prescription or not, without first telling your doctor or consulting
Things to be careful of
Be careful driving or operating machinery until you know how CYMEVENE affects you.
CYMEVENE may cause drowsiness, dizziness, confusion or seizures (fits) in some people and therefore may affect alertness.
Make sure you know how you react to CYMEVENE before you drive a car or operate machinery or do anything else that could be
dangerous if you are drowsy, dizzy or not alert.
Tell your doctor or pharmacist as soon as possible if you do not feel well after you have been given CYMEVENE.
CYMEVENE helps most people with CMV infections but it may have unwanted side effects in some people.
Unwanted effects may be due to CYMEVENE, other medications, or any disease or condition you may also have. You should notify
your doctor if these or any other effects occur.
All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical treatment
or a change of therapy if you get some of the side effects.
Ask your doctor or pharmacist to answer any questions you may have.
Do not be alarmed by this list of possible side effects. You may not experience any of them.
Many unwanted effects commonly reported in people with HIV appear to be related to their medical condition. The following
list are unwanted effects seen in people receiving intravenous CYMEVENE which may or may not be caused by their medication:
low white blood cell counts
anaemia (low red blood cell counts).
nausea and/or vomiting
feeling of weakness
low blood platelet count
injection site soreness or redness.
Tell your doctor if you notice any of the following and they are worrying you:
loss of feeling or tingling
difficulty in swallowing
nervousness or feeling anxious
shortness of breath.
If you notice any of the following you should see your doctor immediately:
a deterioration or worsening of your eye sight even if you are receiving CYMEVENE
bruising or purple spots
any sign of infection such as fever, chills, sore throat or mouth ulcers
rapid or irregular heartbeat or sudden fevers
severe allergic reactions causing swelling, rash or itching
severe blisters and bleeding in the lips eyes, mouth, nose and genitals
pain or inflammation in your chest, stomach or intestines
collapse, numbness or weakness of the arms or legs, headache, dizziness and confusion, visual disturbance, difficulty swallowing,
slurred speech and loss of speech
pain, swelling or joint stiffness
change in the amount of urine you pass.
This is not a complete list of all possible side effects. Others may occur in some people and there may be some side effects
not yet known.
Tell your doctor if you notice anything else that is making you feel unwell, even if it is not on this list.
Ask your doctor or pharmacist if you don't understand anything in this list.
After receiving CYMEVENE
CYMEVENE vials and infusion bags will be stored in the pharmacy or on the ward.
What CYMEVENE looks like
CYMEVENE is available as a freeze-dried powder in clear glass vials. It will be made up into an infusion bag before being
given to you.
Each 10 mL CYMEVENE vial contains:
543 mg of ganciclovir sodium equivalent to 500 mg of ganciclovir
There are no other ingredients in CYMEVENE vials.
CYMEVENE does not contain gluten, lactose, sucrose, tartrazine or any other azo dyes.
CYMEVENE is distributed by:
Roche Products Pty Limited
ABN 70 000 132 865
4 - 10 Inman Road
Dee Why NSW 2099
Customer enquiries: 1800 233 950
Please check with your pharmacist for the latest Consumer Medicine Information.
Australian Registration Number
AUST R 10047
This leaflet was prepared on 03 April 2017